AMED portfolio
AMED has 4 portfolio companies on record at Recent Funding, with 1 investment in the last 12 months.
About this page
Its most recent investment on record is Laza Medical's $160M Series B+ round in November 2026, alongside GE Healthcare, PA MedTech VC Fund and Unorthodox Ventures. By category, its portfolio leans toward Health and bio (4) and Robotics and hardware (1).
What AMED invests in
- Health and bio · 4 · 100%
- Robotics and hardware · 1 · 25%
- Consumer and social · 1 · 25%
How AMED invests
| Stage | Deals | Capital in rounds |
|---|---|---|
| Series B+ | 1 100% | $160M |
AMED portfolio companies
LLaza Medical$160MSeries B+ · Nov 2026
AAvenCellbacker
RRejonibacker
CCORE Biomedicinebacker
| Company | Round with AMED | Total raised | Latest raise |
|---|---|---|---|
Health and bio |
Series B+ · $160M | $196M | Nov 4, 2026 Series B+ |
Health and bio |
backer | $112M | Oct 22, 2024 Series B+ |
Health and bio |
backer | $25M | Jun 16, 2026 round |
Health and bio |
backer | $21M | Jul 28, 2026 Series A |
Most frequent co-investors
UUnorthodox Ventures1 shared round · last Nov 4, 2026
GGE Healthcare1 shared round · last Nov 4, 2026
- PPA MedTech VC Fund1 shared round · last Nov 4, 2026
Similar investors
AAble Partners4 companies · 1 deal in 12 mo
BBdc Thrive venture5 companies · 3 deals in 12 mo
BBpifrance Digital Venture5 companies · 3 deals in 12 mo
CCambridge Enterprise Ventures5 companies · 3 deals in 12 mo
HHealthier Capital5 companies · 3 deals in 12 mo
VVirginia Innovation Partnership Corporation5 companies · 3 deals in 12 mo
Investors whose portfolios on Recent Funding center on the same category (Health and bio).
How this is counted
Share is of the 1 round on Recent Funding that name AMED. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.
Portfolio companies are the companies on Recent Funding with a round that lists AMED, which is a subset of its real portfolio. API: /api/v1/investors/amed (get a free API key). More: the most active VC firms and new venture capital funds.